Mechanisms of Control of Type 2 Diabetes with Gastric Bypass

[1]  F. Villarroya,et al.  FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss. , 2017, Clinical nutrition.

[2]  G. Frühbeck,et al.  Metabolic Surgery Enters the T2DM Treatment Algorithm , 2016, Trends in Endocrinology & Metabolism.

[3]  P. Schauer,et al.  Effect of Roux-en-Y Gastric Bypass on the NLRP3 Inflammasome in Pancreatic Islets from Zucker Diabetic Fatty Rats , 2016, Obesity Surgery.

[4]  G. Frühbeck,et al.  Increased Interleukin-32 Levels in Obesity Promote Adipose Tissue Inflammation and Extracellular Matrix Remodeling: Effect of Weight Loss , 2016, Diabetes.

[5]  Suisha Liang,et al.  Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota , 2016, Genome Medicine.

[6]  W. D. de Vos,et al.  Causality of small and large intestinal microbiota in weight regulation and insulin resistance , 2016, Molecular metabolism.

[7]  Xiaokun Li,et al.  Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases , 2016, Journal of diabetes research.

[8]  S. Ikramuddin,et al.  FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes , 2016, Obesity Surgery.

[9]  P. Rorsman,et al.  PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery , 2016, Cell reports.

[10]  F. Pattou,et al.  Bile Diversion in Roux-en-Y Gastric Bypass Modulates Sodium-Dependent Glucose Intestinal Uptake. , 2016, Cell metabolism.

[11]  Giuseppe d'Annunzio,et al.  A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes , 2015, Journal of diabetes research.

[12]  J. Frystyk,et al.  Enhanced insulin signaling in human skeletal muscle and adipose tissue following gastric bypass surgery. , 2015, American journal of physiology. Regulatory, integrative and comparative physiology.

[13]  Fredrik H. Karlsson,et al.  Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation , 2015, Cell metabolism.

[14]  C. Apovian,et al.  Improved Insulin Sensitivity 3 Months After RYGB Surgery Is Associated With Increased Subcutaneous Adipose Tissue AMPK Activity and Decreased Oxidative Stress , 2015, Diabetes.

[15]  S. Ikramuddin,et al.  Roux-en-Y Gastric Bypass Acutely Decreases Protein Carbonylation and Increases Expression of Mitochondrial Biogenesis Genes in Subcutaneous Adipose Tissue , 2015, Obesity Surgery.

[16]  N. Calakos,et al.  Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. , 2015, The Journal of clinical investigation.

[17]  H. Pijl,et al.  Calorie restriction and Roux‐en‐Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects , 2014, Clinical endocrinology.

[18]  G. Frühbeck,et al.  Need for a Paradigm Shift in Adult Overweight and Obesity Management - an EASO Position Statement on a Pressing public Health, Clinical and Scientific Challenge in Europe , 2014, Obesity Facts.

[19]  Reneé H Moore,et al.  GLP-1 Plays a Limited Role in Improved Glycemia Shortly After Roux-en-Y Gastric Bypass: A Comparison With Intensive Lifestyle Modification , 2014, Diabetes.

[20]  I. Godsland,et al.  Combination of Peptide YY3–36 with GLP-17–36 amide Causes an Increase in First-Phase Insulin Secretion after IV Glucose , 2014, The Journal of clinical endocrinology and metabolism.

[21]  D. Giannella‐Neto,et al.  Relationship between gut hormones and glucose homeostasis after bariatric surgery , 2014, Diabetology & Metabolic Syndrome.

[22]  G. Bewick,et al.  Peptide YY: more than just an appetite regulator , 2014, Diabetologia.

[23]  Yong Wang,et al.  Gastric Bypass Surgery May Improve Beta Cell Apoptosis with Ghrelin Overexpression in Patients with BMI ≥ 32.5 kg/m2 , 2014, Obesity Surgery.

[24]  N. Musi,et al.  Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle , 2013, PloS one.

[25]  A. Lacy,et al.  GLP-1 Action and Glucose Tolerance in Subjects With Remission of Type 2 Diabetes After Gastric Bypass Surgery , 2013, Diabetes Care.

[26]  J. H. Bekker,et al.  The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. , 2012, Endocrinology.

[27]  Rennian Wang,et al.  Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes , 2012, Nature Medicine.

[28]  J. Holst,et al.  Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass , 2012, Diabetologia.

[29]  C. Apovian,et al.  Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue[S] , 2012, Journal of Lipid Research.

[30]  T. Lam,et al.  Lipid sensing in the gut, brain and liver , 2012, Trends in Endocrinology & Metabolism.

[31]  A. Cherrington,et al.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. , 2012, The Journal of clinical investigation.

[32]  K. Cianflone,et al.  Complement C3 and cleavage products in cardiometabolic risk. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[33]  B. Staels,et al.  Bile Acid Metabolism and the Pathogenesis of Type 2 Diabetes , 2011, Current diabetes reports.

[34]  A. Darzi,et al.  Gut microbiome-host interactions in health and disease , 2011, Genome Medicine.

[35]  S. Kini,et al.  GIP and Bariatric Surgery , 2011, Obesity surgery.

[36]  Yong Wang,et al.  Adiponectin Downregulates Hyperglycemia and Reduces Pancreatic Islet Apoptosis After Roux-En-Y Gastric Bypass Surgery , 2011, Obesity surgery.

[37]  C. Apovian,et al.  Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. , 2011, Biochemical and biophysical research communications.

[38]  S. Rabot,et al.  Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  J. Tap,et al.  Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss , 2010, Diabetes.

[40]  Aamir Suhail,et al.  Adiponectin-induced ERK and Akt Phosphorylation Protects against Pancreatic Beta Cell Apoptosis and Increases Insulin Gene Expression and Secretion* , 2010, The Journal of Biological Chemistry.

[41]  B. Finlay,et al.  Gut microbiota in health and disease. , 2010, Physiological reviews.

[42]  N. Abumrad,et al.  The Importance of Caloric Restriction in the Early Improvements in Insulin Sensitivity After Roux-en-Y Gastric Bypass Surgery , 2010, Diabetes Care.

[43]  A. Tavakkolizadeh,et al.  Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[44]  J. Auwerx,et al.  TGR5-mediated bile acid sensing controls glucose homeostasis. , 2009, Cell metabolism.

[45]  J. Holst,et al.  Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism , 2009, Obesity.

[46]  D. Cummings,et al.  Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. , 2009, Endocrinology.

[47]  B. Bouscarel,et al.  Bile acids and signal transduction: role in glucose homeostasis. , 2008, Cellular signalling.

[48]  B. Viollet,et al.  Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. , 2008, Cell metabolism.

[49]  Johan Auwerx,et al.  Targeting bile-acid signalling for metabolic diseases , 2008, Nature Reviews Drug Discovery.

[50]  P. Light,et al.  Upper intestinal lipids trigger a gut–brain–liver axis to regulate glucose production , 2008, Nature.

[51]  L. Fulton,et al.  Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. , 2008, Cell host & microbe.

[52]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[53]  J. Kral,et al.  Impact of Gastric Bypass Surgery on Gut Hormones and Glucose Homeostasis in Type 2 Diabetes , 2006, Diabetes.

[54]  Folkert Kuipers,et al.  The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice* , 2006, Journal of Biological Chemistry.

[55]  J. Chan,et al.  Peptide YY Levels Are Elevated After Gastric Bypass Surgery , 2006, Obesity.

[56]  P. Misery,et al.  Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. , 2005, Cell metabolism.

[57]  S. Kliewer,et al.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.

[58]  J. Manson,et al.  Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. , 2005, The Journal of clinical endocrinology and metabolism.

[59]  K. Knobeloch,et al.  Mice without the Regulator Gene Rsc1A1 Exhibit Increased Na+-d-Glucose Cotransport in Small Intestine and Develop Obesity , 2005, Molecular and Cellular Biology.

[60]  G. Frühbeck,et al.  Fasting Plasma Ghrelin Concentrations 6 Months after Gastric Bypass are not Determined by Weight Loss or Changes in Insulinemia , 2004, Obesity surgery.

[61]  G. Frühbeck,et al.  The Decrease in Plasma Ghrelin Concentrations following Bariatric Surgery Depends on the Functional Integrity of the Fundus , 2004, Obesity surgery.

[62]  G. Mithieux,et al.  Induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes. , 2004, American journal of physiology. Endocrinology and metabolism.

[63]  G. Frühbeck,et al.  Fundus functionality and ghrelin concentrations after bariatric surgery. , 2004, The New England journal of medicine.

[64]  Yu Wang,et al.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.

[65]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[66]  S. Shirazi-Beechey,et al.  Expression of monosaccharide transporters in intestine of diabetic humans. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[67]  R. Burcelin,et al.  Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. , 2000, Diabetes.

[68]  G. Dohm,et al.  A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? , 1998, Annals of surgery.

[69]  W. Pories,et al.  Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult‐Onset Diabetes Mellitus , 1995, Annals of surgery.

[70]  J M Polak,et al.  Human distribution and release of a putative new gut hormone, peptide YY. , 1985, Gastroenterology.

[71]  Jon Gabrielsen,et al.  Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. , 2014, The lancet. Diabetes & endocrinology.

[72]  S. Woods,et al.  Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. , 2013, Endocrinology.

[73]  B. Staels,et al.  Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.